Successful execution of established brand strategies requires developing specific operational capabilities. This includes developing efficient shared services, streamlined compliance processes, and ...

This time I’m going to focus on one company and its view on pharma’s digital commercial strategy ... joined Pfizer in 2019, bringing more than 20 years of healthcare experience from companies ...

Touchcast’s AI technology to be integrated with Infinite Reality’s portfolio of products and services including Napster, iR ...

TrackerRMS, a global leader in applicant tracking systems (ATS) and customer relationship management (CRM) software for the recruitment and staffing industry, has expanded its leadership team with the ...

Sachin Talwalkar highlights the urgent need for healthcare brands to combat misinformation by building trust through transparent, expert-backed, and more.

ANAHEIM, CA / ACCESS Newswire / April 16, 2025 / Phoenix Motor Inc. dba PhoenixEV , a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, ...

Pfizer faces significant revenue pressure from ... based on 1% dividend growth for the next five years. My dynamic hedging strategy with long Put options yielded a 2.65% ROI in a low IV ...

Tony Hogben is the Immersive Studio Lead at Pfizer Digital Omnichannel Services & Solutions (OSS). Pfizer Digital Omnichannel ...

The key to a successful personalized experience is listening, and providing customers with the unique touches that connect with them. Use data and customer surveys to gain buyer insights and ...

GenAI can analyze large sets of data, including every customer interaction, the customers' sentiments before and after interacting with the agents and their actions on the company’s website. Using ...

Pfizer has been getting a bad rap on Wall Street ... has more than two decades of semiconductor industry and software experience. Importantly, he's not afraid to simplify Intel's operations ...

GSK resolves patent lawsuit against Pfizer over RSV vaccines British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial ...